Pirenzepine Hydrochloride

盐酸哌仑西平

Report date: 2023/02/21 17:29:08
NME

Base Information

Drug NamePirenzepine Hydrochloride
Drug Alias Namepirenzepinum哌仑西平yanpirenzepina哌仑西平Gastrozepin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsDiabetes MellitusPolyneuropathiesDiabetic Neuropathies +[6] 
Global Approved IndicationsPeptic UlcerGastritis
Approved Indications in ChinaPeptic UlcerGastritis
Original Approved Country/TerritoryJapan
Original Approved Date1990/07/01
Country/TerritoryCanadaUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWinsantor Inc
China Registration ClassN/A

Develop Information

Active CompaniesWinsantor IncSawai Pharmaceutical Co Ltd Kashima FactorySuzhou Homesun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusPolyneuropathiesDiabetic Neuropathies +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeA02BX03
Related LinksWikipediaDrugBankKEGG